TRG Management backs Amethyst Radiotherapy

TRG plans to accelerate the growth of the business across Europe through the roll-up of clinics, the development of greenfield centres and outsourcing partnerships with hospitals.

Also known as The Rohatyn Group, TRG was founded by Nicolas Rohatyn in 2002 and typically invests in emerging markets. The firm is headquartered in New York.

Previous funding
Mezzanine Management provided expansion capital to Amethyst in 2014 via its Accession Mezzanine Capital III fund. The investor stated the exit generated a "very strong" multiple and "private-equity-like" IRR.

Mezzanine Management initially provided a structured growth package worth €18m, comprising both mezzanine and minority equity. The funds were used to support Amethyst’s local and international expansion, namely expanding into Poland, France, Italy and Austria.

Company
Amethyst, founded in 2010, operates nine radiotherapy clinics across France, Romania, Italy, Poland and Austria. It provides radiotherapy treatment for most types of common cancers, according to a statement by TRG. The company is headquartered in Otopeni.

People
TRG Management – Nick Rohatyn (CEO); Colin Clark (head of CEE EMEA private markets investing); Sobhi Hatem (managing director).
Amethyst Radiotherapy – Ludovic Robert (co-founder). 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• CEE
• Healthcare
• Romania